Newlimit, the longevity biotech co-founded by Coinbase CEO Brian Armstrong, has raised $435 million in a Series C round led by Founders Fund, roughly tripling the company’s valuation to about $3.1 billion. Crypto Wealth Flows Into Longevity Science Newlimit, the anti-aging biotech co-founded by Coinbase Global Inc. (Nasdaq: COIN) Chief Executive Brian Armstrong, has closed […]
